Expo Hub
The NAEOTOM Alpha class
Unstoppable
Patient-centered innovation is at the core of Siemens Healthineers. Since 2021, NAEOTOM® Alpha with Quantum Technology, the world’s first photon-counting CT, has been transforming clinical practice and helping radiologists make a difference in the lives of over one million patients with profound insights that are unattainable with conventional CT technology in many cases.1
By making this powerful technology accessible to more clinicians and patients, we are delivering on our promise to innovate ahead. Presenting the NAEOTOM® Alpha class: Images that provide profound clinical impact that support physicians in diagnosing targeted clinical inquiries are accompanied by the AI-powered productivity of myExam Companion that can speed up workflows by up to 82%.2 Three versatile photon-counting CT scanners that are all powered by Quantum Technology are leading the way to a new standard in diagnostic imaging.
This new standard is the unstoppable solution that answers the increasing demand for conclusive CT results throughout the patient pathway. Support your clinical and institutional growth with our future-proof portfolio to deliver the outcomes needed to thrive in the future, today.
Related sessions
1 / 0
How photon-counting detector CT impacts on my clinical practice – Pre-procedural planning for structural heart disease
A presentation on the benefits of photon-counting CT technology in cardiac imaging.
Photon-counting CT in Neuroradiology: SIH and the Elusive CSF-Venous Fistula
A presentation of evidence of the benefits of PCCT in discovering the site of CSF fistulas.
Photon-counting CT imaging of the Liver: Improving lesion detection while reducing radiation dose
A presentation about the impact of PCCT in detecting lesions in the liver at reduced radiation dose.
NAEOTOM Alpha: Clinical advancements in CT imaging for next-generation technology – Impact on neuroradiology and pediatric radiology
A presentation illustrating the uses of PCCT in the NAEOTOM Alpha in neuro and pediatric radiology.
NAEOTOM Alpha: Clinical advancements in CT imaging for next-generation technology, clinical insights oncology
A presentation of the benefits of photon-counting technology in oncology imaging.
Clinical Imaging
1 / 0
Plaque evaluation
- Plaque assessment at 0.2 mm slice thickness delivers high spatial resolution compared to 0.6 mm.
Stent assessment
- Quantum HD Cardiac with 0.2 mm slice thickness with NAEOTOM Alpha enables the visualization of coronary stents for the assessment of in-stent restenosis.
1 / 0
Spectral information
- Spectral information is combined with high resolution to assess pancreatic insulinoma with high precision compared to conventional CT and MRI.
- Inherently available spectral information for the evaluation of challenging lesions: a game changer for precision diagnostics.
1 / 0
Quantum HD imaging
- Quantum HD resolution for lung fibrosis assessment with high level of detail for precise diagnosis at low dose.
Spectral information
- The combination of morphological and functional information provides pulmonary embolism assessment in one scan.1
1 / 0
Quantum HD head stent imaging
Cerebral CTA follow-up after an intervention
1 / 0
Low-dose imaging
- Low-dose pediatric PCCT with intrinsic spectral information captures pediatric truncus arteriosus communis with high detail.
Spectral information
- Pediatric oncology assessment displaying metal artefact in a pediatric PCCT scan.
1 / 0
Quantum HD
Revealing fine details with Quantum HD images for the assessment of tibia osteomyelitis.
Quantum spectral imaging
Quantum HD ankle imaging combined with bone marrow spectral evaluation2.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
1data on file
2Results from case studies are not predictive of results in other cases. Results in other cases may vary. Study source: Testing bay environment study, Forchheim, Germany